Internal Medicine, Endocrinology, Diabetes, & Metabolism · Pensacola, FL
NPI
1598710428
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
5149 N 9th Ave, G32
Pensacola, FL, 32504
Phone (850) 416-6450
Groups this clinician bills Medicare through
Medicare paid, 2024
$160K
2,660 services
Medicare patients, 2024
1,423
Average age 74
Drug cost, 2024
$1.3M
4,596 prescriptions
Company payments, 2024
$94.68
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ziad M Mamish was code 99232 (hospital e&m - subsequent), 597 times for 207 patients. In total Ziad M Mamish billed 2,660 services in 20 codes, and Medicare paid $160K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 597 | 207 | $62.03 | $37K |
| 99214 Office E&M - Established | Office | 589 | 516 | $70.33 | $41K |
| 77080 Standard X-ray | Office | 462 | 462 | $9.75 | $4,503 |
| 99213 Office E&M - Established | Office | 167 | 159 | $49.48 | $8,263 |
| 99222 Hospital E&M - Initial | Facility | 153 | 151 | $97.94 | $15K |
| 99215 Office E&M - Established | Office | 126 | 119 | $101.49 | $13K |
| 99205 Office E&M - New | Office | 104 | 104 | $130.72 | $14K |
| 99223 Hospital E&M - Initial | Facility | 75 | 73 | $131.07 | $9,831 |
| 76536 Ultrasound - Nonspecific | Office | 60 | 58 | $19.06 | $1,144 |
| 99204 Office E&M - New | Office | 57 | 57 | $92.02 | $5,245 |
| 10006 Other Organ Systems | Office | 37 | 21 | $41.90 | $1,550 |
| 99233 Hospital E&M - Subsequent | Facility | 36 | 34 | $93.39 | $3,362 |
| 99203 Office E&M - New | Office | 32 | 32 | $64.12 | $2,052 |
| 10005 Other Organ Systems | Office | 27 | 26 | $59.03 | $1,594 |
By year: 2022 $163K for 3,901 services; 2023 $174K for 3,173 services; 2024 $160K for 2,660 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ziad M Mamish prescribed most often to Medicare patients was Levothyroxine Sodium, with 639 prescriptions and refills. In total Ziad M Mamish wrote 4,596 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 639 | 1,795 | 216 | $7,272 |
| Methimazole Generic | 276 | 715 | 96 | $3,788 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 259 | 535 | 95 | $40K |
| Metformin Hcl Generic | 214 | 595 | 82 | $1,736 |
| Humalog Kwikpen U-100 Insulin Lispro | 199 | 383 | 73 | $66K |
| Synthroid Levothyroxine Sodium | 157 | 402 | 47 | $13K |
| Novolog Flexpen Insulin Aspart | 131 | 263 | 49 | $40K |
| Ozempic Semaglutide | 116 | 189 | 36 | $134K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 114 | 232 | 48 | $13K |
| Glimepiride Generic | 100 | 280 | 41 | $809 |
| Metformin Hcl Er Metformin Hcl | 90 | 237 | 32 | $940 |
| Insulin Lispro Kwikpen U-100 Insulin Lispro | 87 | 141 | 31 | $23K |
| Pioglitazone Hcl Generic | 87 | 185 | 22 | $1,115 |
| Humalog Mix 75-25 Kwikpen Insulin Lispro Protamin/Lispro | 87 | 138 | 29 | $30K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 71 | 114 | 20 | $25K |
Brand drugs: 2,369 claims; generic drugs: 1,776 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Ziad M Mamish $94.68 ($94.68 in general payments such as food, travel and fees) from 1 company. The largest payer was Amgen Inc. with $94.68.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 1 | $94.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.